Monday, September 14, 2026

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

LS Group Plans Essex IPO to Ride U.S. Power Supercycle: What the Listing Means for Corporate Value

LS Group plans to list Essex Solutions to raise $375M for expansion, countering claims of a split listing and enhancing corporate value.

Tariffs 15% to 25%: Trump Move Heads for the Federal Register as Seoul Scrambles to Pass U.S. Investment Law by Next Month

President Trump's 25% tariff on Korean imports sparks urgent negotiations and political maneuvering in South Korea's National Assembly.

Tag: Stray Kids

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.